Calcium responses to synaptically activated bursts of action potentials and their synapse-independent replay in cultured networks of hippocampal neurons.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 23360982)

Published in Biochim Biophys Acta on January 27, 2013

Authors

C Peter Bengtson1, Martin Kaiser, Joshua Obermayer, Hilmar Bading

Author Affiliations

1: Department of Neurobiology, University of Heidelberg, Heidelberg, Germany. Bengtson@nbio.uni-heidelberg.de

Articles by these authors

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci (2010) 5.27

The Yin and Yang of NMDA receptor signalling. Trends Neurosci (2003) 2.83

Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem (2003) 2.20

Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci (2005) 2.16

Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron (2007) 2.08

Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci (2006) 1.94

Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet (2009) 1.72

Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities. Nat Neurosci (2012) 1.66

Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim Biophys Acta (2002) 1.66

Microelectrode array recordings of cultured hippocampal networks reveal a simple model for transcription and protein synthesis-dependent plasticity. J Physiol (2004) 1.41

Synaptic activity induces dramatic changes in the geometry of the cell nucleus: interplay between nuclear structure, histone H3 phosphorylation, and nuclear calcium signaling. J Neurosci (2009) 1.36

Angiogenesis in multiple myeloma. Eur J Cancer (2006) 1.31

Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nat Commun (2013) 1.30

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment. Eur J Haematol (2006) 1.27

Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood (2006) 1.22

Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J Neurochem (2005) 1.22

Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Eur J Haematol (2006) 1.21

A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage. J Neurosci (2011) 1.21

Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr Opin Neurobiol (2003) 1.17

Calcium signaling in synapse-to-nucleus communication. Cold Spring Harb Perspect Biol (2011) 1.12

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Eur J Haematol (2007) 1.11

Activity-dependent calcium signaling and ERK-MAP kinases in neurons: a link to structural plasticity of the nucleus and gene transcription regulation. Cell Calcium (2010) 1.10

Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment. Eur J Haematol (2008) 1.10

Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors. J Biol Chem (2010) 1.09

Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain. Neuron (2013) 1.09

Diffusion and not active transport underlies and limits ERK1/2 synapse-to-nucleus signaling in hippocampal neurons. J Biol Chem (2007) 1.07

Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function. Biochem Biophys Res Commun (2005) 1.07

Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J Neurosci (2009) 1.06

Proteasome: an emerging target for cancer therapy. Anticancer Drugs (2005) 1.04

Nuclear calcium-VEGFD signaling controls maintenance of dendrite arborization necessary for memory formation. Neuron (2011) 1.01

Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease. Biochem Biophys Res Commun (2005) 0.99

High-yield synthesis and structure of double-walled bismuth-nanotubes. Nano Lett (2010) 0.98

Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood (2011) 0.97

Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors. ACS Nano (2010) 0.97

Nuclear calcium sensors reveal that repetition of trains of synaptic stimuli boosts nuclear calcium signaling in CA1 pyramidal neurons. Biophys J (2010) 0.97

A quantitative method to assess extrasynaptic NMDA receptor function in the protective effect of synaptic activity against neurotoxicity. BMC Neurosci (2008) 0.96

Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol (2013) 0.95

Mechanisms underlying the rules for associative plasticity at adult human neocortical synapses. J Neurosci (2013) 0.93

Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib. Clin Lymphoma Myeloma Leuk (2010) 0.93

Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA). Exp Cell Res (2007) 0.93

Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinase. J Cancer Res Clin Oncol (2008) 0.93

Long term recordings with microelectrode arrays: studies of transcription-dependent neuronal plasticity and axonal regeneration. J Physiol Paris (2006) 0.92

Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK. Br J Haematol (2007) 0.90

Nuclear calcium signaling. Adv Exp Med Biol (2012) 0.90

Calcium signaling in cognition and aging-dependent cognitive decline. Biofactors (2011) 0.90

Calcium signals can freely cross the nuclear envelope in hippocampal neurons: somatic calcium increases generate nuclear calcium transients. BMC Neurosci (2007) 0.88

Nuclear calcium signaling regulates nuclear export of a subset of class IIa histone deacetylases following synaptic activity. J Biol Chem (2013) 0.88

Development and validation of a paediatric long-bone fracture classification. A prospective multicentre study in 13 European paediatric trauma centres. BMC Musculoskelet Disord (2011) 0.87

High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia. Leuk Res (2011) 0.87

The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases. Eur J Haematol (2012) 0.86

Adeno-associated virus (AAV)-mediated suppression of Ca2+/calmodulin kinase IV activity in the nucleus accumbens modulates emotional behaviour in mice. BMC Neurosci (2007) 0.86

Bone markers in multiple myeloma. Eur J Cancer (2006) 0.85

Structural dynamics of the cell nucleus: basis for morphology modulation of nuclear calcium signaling and gene transcription. Nucleus (2011) 0.85

Prenatal management of an allantoic cyst with patent urachus. Arch Gynecol Obstet (2009) 0.84

Nuclear calcium signaling controls methyl-CpG-binding protein 2 (MeCP2) phosphorylation on serine 421 following synaptic activity. J Biol Chem (2012) 0.84

Synaptic activity induces signalling to CREB without increasing global levels of cAMP in hippocampal neurons. J Neurochem (2003) 0.83

Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma. Anticancer Drugs (2006) 0.82

A transcription-dependent increase in miniature EPSC frequency accompanies late-phase plasticity in cultured hippocampal neurons. BMC Neurosci (2009) 0.82

Filtering, reconstruction, and measurement of the geometry of nuclei from hippocampal neurons based on confocal microscopy data. J Biomed Opt (2008) 0.81

Increasing levels of wild-type CREB up-regulates several activity-regulated inhibitor of death (AID) genes and promotes neuronal survival. BMC Neurosci (2012) 0.81

Quenching of the upconversion luminescence of NaYF₄:Yb³⁺,Er³⁺ and NaYF₄:Yb³⁺,Tm³⁺ nanophosphors by water: the role of the sensitizer Yb³⁺ in non-radiative relaxation. Nanoscale (2015) 0.80

Molecular and clinical aspects of proteasome inhibition in the treatment of cancer. Recent Results Cancer Res (2007) 0.80

The divergence-convergence model of acquired neuroprotection. Mech Dev (2012) 0.79

Requirement for nuclear calcium signaling in Drosophila long-term memory. Sci Signal (2013) 0.79

Gut-derived factors promote neurogenesis of CNS-neural stem cells and nudge their differentiation to an enteric-like neuronal phenotype. Am J Physiol Gastrointest Liver Physiol (2011) 0.79

Water dispersible upconverting nanoparticles: effects of surface modification on their luminescence and colloidal stability. Nanoscale (2015) 0.78

The nuclear calcium signaling target, activating transcription factor 3 (ATF3), protects against dendrotoxicity and facilitates the recovery of synaptic transmission after an excitotoxic insult. J Biol Chem (2014) 0.78

Reliable optical detection of coherent neuronal activity in fast oscillating networks in vitro. Neuroimage (2011) 0.78

Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure. Neuropharmacology (2013) 0.76

A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue. Leuk Lymphoma (2014) 0.76

Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma. Exp Cell Res (2009) 0.76

Absolute photoluminescence quantum yields of IR26 and IR-emissive Cd(1-x)Hg(x)Te and PbS quantum dots--method- and material-inherent challenges. Nanoscale (2015) 0.76

BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma. Eur J Haematol (2010) 0.76

Dysfunction of neuronal calcium signaling in aging and disease. Cell Tissue Res (2014) 0.76

The Intermetalloid Cluster Cation (CuBi8)3. Chemistry (2017) 0.75

[Limitations and possibilities of applying the positive effects of human/animal relations in the treatment of psychological ailments]. Bull Soc Sci Med Grand Duche Luxemb (2005) 0.75

Molecular phylogenetic relationship of snow finch complex (genera Montifringilla, Pyrgilauda, and Onychostruthus) from the Tibetan plateau. Mol Phylogenet Evol (2006) 0.75

Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia. Leuk Res (2010) 0.75